“Pidotimod in paucisymptomatic SARS-CoV2 infected patients: Pidotimod in COVID-19”, Mediterr J Hematol Infect Dis, vol. 12, no. 1, p. e2020048, Jun. 2020, doi: 10.4084/mjhid.2020.048.